CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation With Techorizon

CROMSOURCE

CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation With Techorizon

PR83128

VERONA, Italy, March 3, 2020 /PRNewswire=KYODO JBN/ --

CROMSOURCE announced today the achievement of a significant milestone in the

digital management of clinical research projects for their clients. In February

2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced

TheClinical digital environment. TheClinical, developed by Techorizon, consists

of customisable, integrated modules dedicated to the efficient digital

management of every aspect of clinical research and development projects.

Logo:

https://mma.prnewswire.com/media/1097884/CROMSOURCE___Techorizon_Logo.jpg  

'Digitalisation is a key foundation of our working philosophy, and has been a

significant source of our investment for many years', commented CROMSOURCE CEO,

Dr. Oriana Zerbini. 'Our adoption and development of digital technologies

provides our clients with benefits in efficiency, quality and visibility on

their projects.'

'Our clients typically first consider CROMSOURCE in order to benefit from the

flexibility, experience and client focus for which we are already recognised',

added Kerry Dyson, Chief Operating Officer at CROMSOURCE. 'When they realise

that we also offer a suite of integrated in-house digital services uncommon in

other providers of mid-size, the strategic benefit to selecting CROMSOURCE as a

partner becomes clear'.

'As a member of the CROMSOURCE group of companies, Techorizon has been able to

develop digital applications which reflect exactly the needs of sponsors and

service providers working in clinical research', noted Silvio Severini,

Managing Director of Techorizon. 'The maturity and reliability of our fully

validated systems is reflected by reaching this important milestone of the

1000th project to be managed in our TheClinical environment by CROMSOURCE.'

About CROMSOURCE

CROMSOURCE is an ISO-certified, international contract research organisation

providing a comprehensive portfolio of services to the pharmaceutical,

biotechnology, and medical device industries. Specialising in clinical

development and staffing solutions, we offer a flexible approach to ensure our

clients' unique needs are supported. CROMSOURCE is unparalleled in offering an

End-to-End Guarantee covering trial timelines, enrolment, and price. CROMSOURCE

operates offices across all regions of Europe and North America. For more

information, visit www.cromsource.com.

About TECHORIZON

Techorizon are technology experts supplying the biopharmaceutical and medical

device industries with advanced IT solutions and services. As a subsidiary of

CROMSOURCE, Techorizon combines technical expertise with a deep understanding

of clinical research processes to deliver to its clients innovative and

customised technology solutions which seamlessly integrate to support all

aspects of clinical development. For more information, visit

www.techorizon.com.   

SOURCE: CROMSOURCE  

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中